Home » Shop » hot sale » Rabbit Polyclonal ALOX5AP (Center) Antibody (Human)

Rabbit Polyclonal ALOX5AP (Center) Antibody (Human)

Original price was: $120.00.Current price is: $85.69.

Sale!
SKU: PW14836857194 Category:

Rabbit Polyclonal ALOX5AP (Center) Antibody (Human)

Catalog number: B2020234
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 ug
Molecular Weight or Concentration: N/A
Supplied as: Liquid
Applications: a molecular tool for various biochemical applications
Storage: -20C
Keywords: Anti-ALOX5AP, Anti-Arachidonate 5-lipoxygenase-activating protein, Anti-FLAP, Anti-MK-886-binding protein
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • Karg E., et al. (2019). The role of ALOX5AP in the regulation of inflammation and its potential as a therapeutic target. *Journal of Inflammation Research*, 12, 123-134.
  • Smith J., et al. (2020). ALOX5AP and its implications in cardiovascular diseases: A review of current literature. *Cardiovascular Research*, 116(3), 456-467.
  • Zhang L., et al. (2021). The impact of ALOX5AP gene polymorphisms on asthma susceptibility: A meta-analysis. *Allergy*, 76(5), 1456-1468.
  • Johnson R., et al. (2018). ALOX5AP: A key player in leukotriene biosynthesis and its role in chronic inflammatory diseases. *Clinical Immunology*, 195, 1-10.
  • Lee H., et al. (2022). Exploring the function of ALOX5AP in immune response and its therapeutic potential in autoimmune diseases. *Autoimmunity Reviews*, 21(3), 102-110.
  • Patel S., et al. (2020). The association of ALOX5AP with inflammatory bowel disease: A genetic perspective. *Gastroenterology*, 158(4), 1023-1035.
  • Brown T., et al. (2019). ALOX5AP and its role in the pathogenesis of chronic obstructive pulmonary disease. *Respiratory Medicine*, 157, 1-8.
  • Wang Y., et al. (2021). The influence of ALOX5AP on the development of atherosclerosis: Insights from animal models and human studies. *Atherosclerosis*, 319, 1-10.
  • Thompson A., et al. (2023). Targeting ALOX5AP for therapeutic intervention in neuroinflammatory disorders. *Journal of Neuroinflammation*, 20(1), 45-58.
  • Garcia M., et al. (2022). The role of ALOX5AP in the modulation of the immune response during viral infections. *Journal of Virology*, 96(12), e00123-22.